CoChat

Glucocorticoid Receptor 1B and 1C mRNA Transcript Alterations in Schizophrenia and Bipolar Disorder, and Their Possible Regulation by GR Gene Variants

Open access
Sinclair, Duncan, Fullerton, Janice M., Webster, Maree J., Shannon Weickert, Cynthia · 2012 · PLoS ONE

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Abnormal patterns of HPA axis activation, under basal conditions and in response to stress, are found in individuals with schizophrenia and bipolar disorder. Altered glucocorticoid receptor (GR) mRNA and protein expression in the dorsolateral prefrontal cortex (DLPFC) in psychiatric illness have also been reported, but the cause of these abnormalities is not known. We quantified expression of GR mRNA transcript variants which employ different 5' promoters, in 35 schizophrenia cases, 31 bipolar disorder cases and 34 controls. We also explored whether sequence variation within the NR3C1 (GR) gene is related to GR mRNA variant expression. Total GR mRNA was decreased in the DLPFC in schizophrenia cases relative to controls (15.1%, p<0.0005) and also relative to bipolar disorder cases (8.9%, p<0.05). GR-1B mRNA was decreased in schizophrenia cases relative to controls (20.2%, p<0.05), while GR-1C mRNA was decreased in both schizophrenia and bipolar disorder cases relative to controls (16.1% and 17.2% respectively, both p<0.005). A dose-dependent effect of rs10052957 genotype on GR-1B mRNA expression was observed, where CC homozygotes displayed 18.4% lower expression than TC heterozygotes (p<0.05), and 31.8% lower expression than TT homozygotes (p<0.005). Similarly, a relationship between rs6190 (R23K) genotype and GR-1C expression was seen, with 24.8% lower expression in GG homozygotes than GA heterozygotes (p<0.01). We also observed an effect of rs41423247 (Bcl1) SNP on expression of 67 kDa GRα isoform, the most abundant GRα isoform in the DLPFC. These findings suggest possible roles for the GR-1B and GR-1C promoter regions in mediating GR gene expression changes in psychotic illness, and highlight the potential importance of sequence variation within the NR3C1 gene in modulating GR mRNA expression in the DLPFC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0031720

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Structure of the GR gene (NR3C1). Map illustrates functional SNPs present in the gene and the generation of GR mRNA variants by inclusion of various exon 1 s in the mRNA 5′ UTR. SNP- single nucleotide polymorphism, UTR- untranslated region, b- base pairs, Chr- chromosome.
Figure 1 Structure of the GR gene (NR3C1). Map illustrates functional SNPs present in the gene and the generation of GR mRNA variants by inclusion of various exon 1 s in the mRNA 5′ UTR. SNP- single nucleotide polymorphism, UTR- untranslated region, b- base pairs, Chr- chromosome.CC BY · PubMed Central
Figure 2 Endpoint PCR detection of GR exon 1 mRNA transcript variants in the DLPFC. A) strong amplification of GR-1B, GR-1C and GR-1H variants was evident in DLPFC cDNA, B) weaker amplification of GR-1E and GR-1F variants was observed in the DLPFC, but strong amplification was observed in universal human cDNA, C) GR-1A and GR-1D variants were detected neither in the DLPFC nor in universal cDNA. UNI- universal human cDNA.
Figure 2 Endpoint PCR detection of GR exon 1 mRNA transcript variants in the DLPFC. A) strong amplification of GR-1B, GR-1C and GR-1H variants was evident in DLPFC cDNA, B) weaker amplification of GR-1E and GR-1F variants was observed in the DLPFC, but strong amplification was observed in universal human cDNA, C) GR-1A and GR-1D variants were detected neither in the DLPFC nor in universal cDNA. UNI- universal human cDNA.CC BY · PubMed Central
Figure 3 Expression of pan GR, GR-1B, GR-1C and GR-1H mRNA transcripts in the DLPFC. Control, bipolar disorder and schizophrenia cases from the Stanley Array cohort were used. A) Pan GR mRNA expression was 15.1% lower in schizophrenia cases relative to controls (p<0.0005), and 8.9% lower in schizophrenia cases relative to bipolar disorder cases (p<0.05). B) GR-1B mRNA expression also differed significantly between diagnostic groups, with 20.2% lower GR-1B expression in schizophrenia cases than controls (p<0.05). C) GR-1C mRNA expression was significantly decreased in schizophrenia (16.1%) and bipolar disorder (17.2%) cases relative to controls (both p<0.005). D) A significant effect of diagnosis GR-1H expression was not observed, but a planned post-hoc test revealed a significant difference between bipolar disorder and control groups (p<0.05). Green, orange and blue diamonds represent control, bipolar disorder and schizophrenia cases respectively. Red bars represent group means. * p<0.05, ** p<0.005, *** p<0.0005.
Figure 3 Expression of pan GR, GR-1B, GR-1C and GR-1H mRNA transcripts in the DLPFC. Control, bipolar disorder and schizophrenia cases from the Stanley Array cohort were used. A) Pan GR mRNA expression was 15.1% lower in schizophrenia cases relative to controls (p<0.0005), and 8.9% lower in schizophrenia cases relative to bipolar disorder cases (p<0.05). B) GR-1B mRNA expression also differed significantly between diagnostic groups, with 20.2% lower GR-1B expression in schizophrenia cases than controls (p<0.05). C) GR-1C mRNA expression was significantly decreased in schizophrenia (16.1%) and bipolar disorder (17.2%) cases relative to controls (both p<0.005). D) A significant effect of diagnosis GR-1H expression was not observed, but a planned post-hoc test revealed a significant difference between bipolar disorder and control groups (p<0.05). Green, orange and blue diamonds represent control, bipolar disorder and schizophrenia cases respectively. Red bars represent group means. * p<0.05, ** p<0.005, *** p<0.0005.CC BY · PubMed Central
Figure 4 Effect of suicide on expression of GR mRNA transcripts in the DLPFC. Suicide-positive and suicide-negative control cases, bipolar disorder cases and schizophrenia cases were compared. A) Pan GR mRNA expression; B) GR-1B mRNA expression; C) GR-1C mRNA expression; D) GR-1H mRNA expression. For all transcripts, GR transcript expression was decreased in suicide-negative schizophrenia cases relative to suicide-positive schizophrenia cases and relative to controls (all suicide-negative). For the GR-1C mRNA transcript, expression was decreased in bipolar disorder as well as schizophrenia in suicide-negative cases relative to both suicide-positive cases and controls. Green, orange and blue diamonds represent control, bipolar disorder and schizophrenia cases respectively. Red bars represent group means. Abbreviations: BP- bipolar disorder, SCZ- schizophrenia. * p≤0.05, ** p<0.005, *** p<0.0005.
Figure 4 Effect of suicide on expression of GR mRNA transcripts in the DLPFC. Suicide-positive and suicide-negative control cases, bipolar disorder cases and schizophrenia cases were compared. A) Pan GR mRNA expression; B) GR-1B mRNA expression; C) GR-1C mRNA expression; D) GR-1H mRNA expression. For all transcripts, GR transcript expression was decreased in suicide-negative schizophrenia cases relative to suicide-positive schizophrenia cases and relative to controls (all suicide-negative). For the GR-1C mRNA transcript, expression was decreased in bipolar disorder as well as schizophrenia in suicide-negative cases relative to both suicide-positive cases and controls. Green, orange and blue diamonds represent control, bipolar disorder and schizophrenia cases respectively. Red bars represent group means. Abbreviations: BP- bipolar disorder, SCZ- schizophrenia. * p≤0.05, ** p<0.005, *** p<0.0005.CC BY · PubMed Central
Figure 5 Effects of rs10052957 (Tth111l) and rs6190 (R23K) genotypes on GR mRNA expression. A) A significant main effect of rs10052957 genotype on GR-1B mRNA expression was identified (ANCOVA F(2, 81) = 5.32, p<0.001), with significant decreases in GR-1B expression in individuals with CC genotype (n = 46) relative to those with TC genotype (n = 40; 18.4% decrease, p<0.05) and TT genotype (n = 9; 31.8% decrease, p<0.005). B) An effect of rs6190 genotype on GR-1C mRNA expression was also observed (Mann-Whitney U-test, z = 2.58, p<0.01), with a 24.8% decrease in GG homozygotes (n = 91) relative to GA heterozygotes (n = 4). Error bars represent SEM. * p<0.05, ** p<0.005.
Figure 5 Effects of rs10052957 (Tth111l) and rs6190 (R23K) genotypes on GR mRNA expression. A) A significant main effect of rs10052957 genotype on GR-1B mRNA expression was identified (ANCOVA F(2, 81) = 5.32, p<0.001), with significant decreases in GR-1B expression in individuals with CC genotype (n = 46) relative to those with TC genotype (n = 40; 18.4% decrease, p<0.05) and TT genotype (n = 9; 31.8% decrease, p<0.005). B) An effect of rs6190 genotype on GR-1C mRNA expression was also observed (Mann-Whitney U-test, z = 2.58, p<0.01), with a 24.8% decrease in GG homozygotes (n = 91) relative to GA heterozygotes (n = 4). Error bars represent SEM. * p<0.05, ** p<0.005.CC BY · PubMed Central
Figure 6 Effect of rs41423247 (Bcl1) genotype on GRα protein expression in the DLPFC. There were significant main effects of genotype on IR band 2 intensity (ANCOVA, F(2, 87) = 4.85, p<0.05) and total IR bands 1–5 (ANOVA F(2, 86) = 3.28, p<0.05). The abundance of IR band 2 (67 kDa GRα) was significantly decreased in rs41423247 GG homozygotes (n = 11; 26.5% decrease, p<0.05) and GC heterozygotes (n = 43; 23.4% decrease, p<0.01) relative to CC homozygotes (n = 41). The total GRα abundance (IR bands 1–5) was decreased (15.1%) in GC heterozygotes relative to CC homozygotes (p<0.05). * p<0.05, ** p = 0.006.
Figure 6 Effect of rs41423247 (Bcl1) genotype on GRα protein expression in the DLPFC. There were significant main effects of genotype on IR band 2 intensity (ANCOVA, F(2, 87) = 4.85, p<0.05) and total IR bands 1–5 (ANOVA F(2, 86) = 3.28, p<0.05). The abundance of IR band 2 (67 kDa GRα) was significantly decreased in rs41423247 GG homozygotes (n = 11; 26.5% decrease, p<0.05) and GC heterozygotes (n = 43; 23.4% decrease, p<0.01) relative to CC homozygotes (n = 41). The total GRα abundance (IR bands 1–5) was decreased (15.1%) in GC heterozygotes relative to CC homozygotes (p<0.05). * p<0.05, ** p = 0.006.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 1

  1. Weickert CS Sheedy D Rothmond DA Dedova I Fung S 2010 Selection of reference gene expression in a schizophrenia brain cohort. Australian and New Zealand Journal of Psychiatry 44 59 70 20073568 PMC2950262 · DOI · Paper page

Cited by

See all 71

Metadata

Authors
Sinclair, D., Fullerton, J. M., Webster, M. J., & Shannon Weickert, C.
Affiliations
  • UNSW Sydney (AU)
  • Uniformed Services University of the Health Sciences (US)
Corresponding author
Sinclair, Duncan
Venue
PLoS ONE
Published
2012-03-13
Volume
7
Issue
3
Pages
e31720
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2044279458
Cited by
71
References
48
Citations by year
2026: 2 · 2025: 1 · 2024: 5 · 2023: 4 · 2022: 6 · 2021: 5 · 2020: 8 · 2019: 2 · 2018: 2 · 2017: 7 · 2016: 7 · 2015: 3 · 2014: 7 · 2013: 10 · 2012: 2
FWCI
5.03
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Stanley Medical Research Institute
  • Neuroscience Research Australia
  • University of New South Wales
  • Macquarie Group Foundation
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
glucocorticoid receptor, NR3C1, schizophrenia, bipolar disorder, dorsolateral prefrontal cortex, hypothalamic-pituitary-adrenal axis, gene expression regulation
MeSH terms
Adult, Analysis of Variance, Bipolar Disorder, Female, Gene Expression Regulation, Genotype, Homozygote, Humans, Male, Middle Aged, Polymorphism, Genetic, Promoter Regions, Genetic, Receptors, Glucocorticoid, RNA, Messenger, Schizophrenia, Suicide, Prefrontal Cortex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucocorticoid Receptor 1B and 1C mRNA Transcript Alterations in Schizophrenia and Bipolar Disorder, and Their Possible Regulation by GR Gene Variants. https://app.cochat.ai/papers/10.1371/journal.pone.0031720
The paper
Sinclair, D., Fullerton, J. M., Webster, M. J., & Shannon Weickert, C. (2012). Glucocorticoid Receptor 1B and 1C mRNA Transcript Alterations in Schizophrenia and Bipolar Disorder, and Their Possible Regulation by GR Gene Variants. PLoS ONE. https://doi.org/10.1371/journal.pone.0031720

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.